Sirtuins, metabolism, and cancer

Frontiers in Pharmacology

Volumn 3 FEB, Issue , 2012, Pages

  Martinez Pastor, Barbara ^a   Mostoslavsky, Raul ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIRTUIN; SIRTUIN 1; SIRTUIN 3; SIRTUIN 6; TRANSCRIPTION FACTOR FKHR;

ARTICLE; DIABETES MELLITUS; DNA DAMAGE; DNA REPAIR; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCOSE METABOLISM; HUMAN; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

EID: 84865979906     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00022     Document Type: Article

References (61)

1. Ashraf, N., Zino, S., Macintyre, A., Kingsmore, D., Payne, A. P., George, W. D., and Shiels, P. G. (2006). Altered sirtuin expression is associated with node-positive breast cancer. Br. J. Cancer 95, 1056-1061.
2. Bell, E. L., Emerling, B. M., Ricoult, S. J. H., and Guarente, L. (2011). SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibit-ing mitochondrial ROS production. Oncogene 30, 2986-2996.
3. Bordone, L., Motta, M. C., Picard, F., Robinson, A., Jhala, U. S., Apfeld, J., McDonagh, T., Lemieux, M., McBurney, M., Szilvasi, A., Easlon, E. J., Lin, S-J., and Guarente, L. (2006). Sirt1 regulates insulin secre-tion by repressing UCP2 in pan-creatic beta cells. PLoS Biol. 4, e31. doi:10.1371/journal.pbio.0040031
4. Chen, W. Y., Wang, D. H., Yen, R. C., Luo, J., Gu, W., and Baylin, S. B. (2005). Tumor suppressor HIC1 directly regulates SIRT1 to mod-ulate p53-dependent DNA-damage responses. Cell 123, 437-448.
5. Chen, Y., Zhang, J., Lin, Y., Lei, G., Guan, K-L., Zhao, S., and Xiong, Y. (2011). Tumour suppressor SIRT3 deacety-lates and activates manganese super-oxide dismutase to scavenge ROS. EMBO Rep. 12, 534-541.
6. Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bron-son, R., Appella, E., Alt, F. W., and Chua, K. F. (2003). Developmen-tal defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 100, 10794-10799.
7. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., and Sinclair, D. A. (2004). Calo-rie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392.
8. Dai, J. M., Wang, Z. Y., Sun, D. C., Lin, R. X., and Wang, S. Q. (2007). SIRT1 interacts with p73 and suppresses p73-dependent tran-scriptional activity. J. Cell. Physiol. 166, 161-166.
9. Deng, C.-X. (2009). SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 5, 147-152.
10. Fan, W., and Luo, J. (2010). SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol. Cell 39, 247-258.
11. Finkel, T., Deng, C. X., and Mostoslavsky, R. (2009). Recent progress in the biology and physiology of sirtuins. Nature 260, 587-591.
12. Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., Pan-dolfi, P. P., and Haigis, M. C. (2011). SIRT3 opposes reprogram-ming of cancer cell metabolism through HIF1α destabilization.Can-cer Cell 19, 416-428.
13. Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Camp-bell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., Hahn, W. C., Guarente, L. P., and Sinclair, D. A. (2008). The SIRT1 deacety-lase suppresses intestinal tumorige-nesis and colon cancer growth. PLoS ONE 3, e2020. doi:10.1371/jour-nal.pone.0002020
14. Ford, J., Jiang, M., and Milner, J. (2005). Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res. 65, 10457-10463.
15. Frescas, D., Valenti, L., and Accili, D. (2005). Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetyla-tion promotes expression of gluco-genetic genes. J. Biol. Chem. 280, 20589-20595.
16. Gerhart-Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S-H., Mostoslavsky, R., Alt, F. W., Wu, Z., and Puigserver, P. (2007). Meta-bolic control of muscle mitochondr-ial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 26, 1913-1923.
17. Hallows, W. C., Lee, S., and Denu, J. M. (2006). Sirtuins deacetylate and acti-vate mammalian acetyl-CoA syn-thetases. Proc. Natl. Acad. Sci. U.S.A. 103,10230-10235.
18. Hallows, W. C., Yu, W., Smith, B. C., Devires, M. K., Ellinger, J. J., Someya, S., Shortreed, M. R., Prolla, T., Markley, J. L., Smith, L. M., Zhao, S., Guan, K.-L., and Denu, J. M. (2011). Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 41,139-149.
19. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
20. Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., and Serrano, M. (2010). Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 1, 3.
21. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Bid-dinger, S., Ilkayeva, O. R., Stevens, R. D., Li, Y., Saha, A. K., Ruderman, N. B., Bain, J. R., Newgard, C. B., Farese, R. V., Alt, F. W., Kahn, C. R., and Verdin, E. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125.
22. Huang, J., Gan, Q., Han, L., Li, J., Zhang, H., Sun, Y., Zhang, Z., and Tong, T. (2008). SIRT1 overexpres-sion antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE 3, e1710. doi:10.1371/jour-nal.pone.0001710
23. Kaidi, A., Weinert, B. T., Choudhary, C., and Jackson, S. P. (2010). Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329, 1348-1353.
24. Kamel, C., Abrol, M., Jardine, K., He, X., and McBurney, M. W. (2006). SirT1 fails to affect p53-mediated biological functions. Aging Cell 5, 81-88.
25. Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., Vassilopoulos, A., Ozden, O., Park, S.-H., Singh, K. K., Abdulka-dir, S. A., Spitz, D. R., Deng, C.-X., and Gius, D. (2010). SIRT3 is a mitochondria-localized tumor sup-pressor required for maintenance of mitochondrial integrity and metab-olism during stress. Cancer Cell 17, 41-52.
26. Kim, J.-E., Chen, J., and Lou, Z. (2008). DBC1 is a negative regulator of SIRT1. Nature 451, 583-586.
27. Li, K., Casta, A., Wang, R., Lozada, E., Fan, W., Kane, S., Ge, Q., Gu, W., Orren, D., and Luo, J. (2008). Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J. Biol. Chem. 283, 7590-7598.
28. Liang, X.-J., Finkel, T., Shen, D.-W., Yin, J.-J., Aszalos, A., and Gottesman, M. M. (2008). SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabo-lism. Mol. Cancer Res. 6, 1499-1506.
29. Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., and Park, J.-W. (2010). Sirtuin 1 modulates cellular responses to hypoxia by deacetylat-ing hypoxia-inducible factor 1alpha. Mol. Cell 38, 864-878.
30. Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., Kim, J., Yan-copoulos, G., Valenzuela, D., Mur-phy, A., Yang, Y., Chen, Y., Hirschey, M. D., Bronson, R. T., Haigis, M., Guarente, L. P., Farese, R. V., Weiss-man, S., Verdin, E., and Schwer, B. (2007). Mammalian Sir2 homolog SIRT3 regulates global mitochondr-ial lysine acetylation. Mol. Cell. Biol. 27, 8807-8814.
31. Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001). Negative con-trol of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148.
32. Mahlknecht, U., Ho, A. D., and Voelter-Mahlknecht, S. (2006). Chromoso-mal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int. J. Oncol. 28, 447-456.
33. Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A., and Gorbunova, V. (2011). SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443-1446.
34. McCord, R. A., Michishita, E., Hong, T., Berber, E., Boxer, L. D., Kusumoto, R., Guan, S., Shi, X., Gozani, O., Burlingame, A. L., Bohr, V. A., and Chua, K. F. (2009). SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging 1, 109-121.
35. Michishita, E., McCord, R.A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawa-hara, T. L., Barret, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O., and Chua, K. F. (2008). SIRT6 is a histone H3 lysine 9 deacetylase that mod-ulates telomeric chromatin. Nature 452, 492-496.
36. Ming, M., Shea, C. R., Guo, X., Li, X., Soltani, K., Han, W., and He, Y.-Y. (2010). Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pig-mentosum C. Proc. Natl. Acad. Sci. U.S.A. 107, 22623-22628.
37. Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., Mills, K. D., Patel, P., Hsu, J. T., Hong, A. L., Ford, E., Cheng, H.-L., Kennedy, C., Nunez, N., Bronson, R., Frendewey, D., Auerbach, W., Valenzuela, D., Karow, M., Hottiger, M. O., Hurst-ing, S., Barrett, J. C., Guarente, L., Mulligan, R., Demple, B., Yancopou-los, G. D., and Alt, F. W. (2006). Genomic instability and aging-like phenotype in the absence of mam-malian SIRT6. Cell 124, 315-329.
38. Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., and Guarente, L. (2004). Mammalian SIRT1 represses forkhead transcrip-tion factors. Cell 116, 551-563.
39. Moynihan, K. A., Grimm, A. A., Plueger, M. M., Bernal-Mizrachi, E., Ford, E., Cras-Méneur, C., Permutt, M. A., and Imai, S-I. (2005). Increased dosage of mammalian Sir2 in pan-creatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2, 105-117.
40. Oberdoerffer, P., Michan, S., McVay, M., Mostoslavsky, R., Vann, J., Park, S.-K., Hartlerode, A., Stegmuller, J., Hafner, A., Loerch, P., Wright, S. M., Mills, K. D, Bonni, A., Yankner, B. A., Scully, R., Prolla, T. A., Alt, F. W., and Sinclair, D. A. (2008). SIRT1 redistribution on chromatin pro-motes genomic stability but alters gene expression during aging. Cell 135, 907-918.
41. Ota, H., Tokunaga, E., Chang, K., Hikasa, M., Iijima, K., Eto, M., Kozaki, K., Akishita, M., Ouchi, Y., and Kaneki, M. (2006). Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 25, 176-185.
42. Palacios, J. A., Herranz, D., De Bonis, M. L., Velasco, S., Serrano, M., and Blasco, M. A. (2010). SIRT1 con-tributes to telomere maintenance and augments global homologous recombination. J. Cell Biol. 191, 1299-1313.
43. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M. W., and Guar-ente, L. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776.
44. Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S.-H. L., Watkins, D. N., Herman, J. G., and Baylin, S. B. (2006). Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2,e40. doi:10.1371/jour-nal.pgen.0020040
45. Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., and Li, X. (2009). Hepatocyte-specific deletion of SIRT1 alters fatty acid metabo-lism and results in hepatic steato-sis and inflammation. Cell Metab. 9, 327-338.
46. Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., and Chen, D. (2010). Calorie restriction reduces oxida-tive stress by SIRT3-mediated SOD2 activation. Cell Metab. 12, 662-667.
47. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. (2005). Nutrient con-trol of glucose homeostasis through a complex of PGC-1a and SIRT1. Nature 434, 3-8.
48. Schwer, B., Bunkenborg, J., Verdin, R. O., Andersen, J. S., and Verdin, E. (2006). Reversible lysine acetylation controls the activity of the mito-chondrial enzyme acetyl-CoA syn-thetase 2. Proc. Natl. Acad. Sci. U.S.A. 103, 10224-10229.
49. Shimazu, T., Hirschey, M. D., Hua, L., Dittenhafer-Reed, K. E., Schwer, B., Lombard, D. B., Li, Y., Bunkenborg, J., Alt, F. W., Denu, J. M., Jacob-son, M. P., and Verdin, E. (2010). SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA syn-thase 2 and regulates ketone body production. Cell Metab. 12,654-661.
50. Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M., and Prolla, T. A. (2010). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812.
51. Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S.-H., Jiang, H., Kim, H.-S., Flynn, C. R., Hill, S., Hayes McDonald, W., Olivier, A. K., Spitz, D. R., and Gius, D. (2010). Sirt3-mediated deacetylation of evo-lutionarily conserved lysine 122 reg-ulates MnSOD activity in response to stress. Mol. Cell 40, 893-904.
52. Van Meter, M., Mao, Z., Gorbunova, V., and Seluanov, A. (2011). Sirt6 over-expression induces massive apopto-sis in cancer cells but not in normal cells. Cell Cycle 10, 1-6.
53. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Under-standing the Warburg effect: the metabolic requirements of cell pro-liferation. Science 324, 1029-1033.
54. Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., and Weinberg, R. A. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159.
55. Wang, R.-H., Sengupta, K., Li, C., Kim, H.-S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., Jia, R., Zheng, Z.-M., Appella, E., Wang, X. W., Ried, T., and Deng, C.-X. (2008). Impaired DNA damage response, genome instability, and tumorigen-esis in SIRT1 mutant mice. Cancer Cell 14, 312-323.
56. Warburg, O., Posener, K., and Negelein, E. (1924). Uber den Stoffwechsel der Carcinomzelle. Biochem. Z. 152, 309-344.
57. Wong, S., and Weber, J. D. (2007). Deacetylation of the retinoblas-toma tumour suppressor protein by SIRT1. Biochem. J. 407, 451-460.
58. Yuan, Z., Zhang, X., Sengupta, N., Lane, W. S., and Seto, E. (2007). SIRT1 reg-ulates the function of the Nijmegen breakage syndrome protein. Mol. Cell 27, 149-162.
59. Zhao, W., Kruse, J.-P., Tang, Y., Jung, S. Y., Qin, J., and Gu, W. (2008). Negative regulation of the deacety-lase SIRT1 by DBC1. Nature 451, 587-590.
60. Zhong, L., D'Urso, A., Toiber, D., Sebas-tian, C., Henry, R. E., Vadysiri-sack, D. D., Guimaraes, A., Marinelli, B., Wikstrom, J. D., Nir, T., Clish, C. B., Vaitheesvaran, B., Iliopoulos, O., Kurland, I., Dor, Y., Weissleder, R., Shirihai, O. S., Ellisen, L. W., Espinosa, J. M., and Mostoslavsky, R. (2010). The histone deacety-lase Sirt6 regulates glucose home-ostasis via Hif1alpha. Cell 140, 280-293.
61. Zhong, L., and Mostoslavsky, R. (2011). Fine tuning our cellular factories: sirtuins in mitochondrial biology. Cell Metab. 13, 621-626.